BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 28882021)

  • 1. Sarcopenia Predicts Prognosis in Patients with Newly Diagnosed Hepatocellular Carcinoma, Independent of Tumor Stage and Liver Function.
    Ha Y; Kim D; Han S; Chon YE; Lee YB; Kim MN; Lee JH; Park H; Rim KS; Hwang SG
    Cancer Res Treat; 2018 Jul; 50(3):843-851. PubMed ID: 28882021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarcopenia, intramuscular fat deposition, and visceral adiposity independently predict the outcomes of hepatocellular carcinoma.
    Fujiwara N; Nakagawa H; Kudo Y; Tateishi R; Taguri M; Watadani T; Nakagomi R; Kondo M; Nakatsuka T; Minami T; Sato M; Uchino K; Enooku K; Kondo Y; Asaoka Y; Tanaka Y; Ohtomo K; Shiina S; Koike K
    J Hepatol; 2015 Jul; 63(1):131-40. PubMed ID: 25724366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma.
    Iritani S; Imai K; Takai K; Hanai T; Ideta T; Miyazaki T; Suetsugu A; Shiraki M; Shimizu M; Moriwaki H
    J Gastroenterol; 2015 Mar; 50(3):323-32. PubMed ID: 24817668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse impact of low skeletal muscle index on the prognosis of hepatocellular carcinoma after hepatic resection.
    Yabusaki N; Fujii T; Yamada S; Suzuki K; Sugimoto H; Kanda M; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2016 Jun; 30():136-42. PubMed ID: 27154615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of muscle depletion and visceral adiposity in HCC patients aged 65 and over undergoing TACE.
    Lim J; Kim KW; Ko Y; Jang IY; Lee YS; Chung YH; Lee HC; Lim YS; Kim KM; Shim JH; Choi J; Lee D
    BMC Cancer; 2021 Oct; 21(1):1164. PubMed ID: 34715813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcopenia Impairs Prognosis of Patients with Hepatocellular Carcinoma: The Role of Liver Functional Reserve and Tumor-Related Factors in Loss of Skeletal Muscle Volume.
    Imai K; Takai K; Watanabe S; Hanai T; Suetsugu A; Shiraki M; Shimizu M
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28937616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.
    Kobayashi T; Kawai H; Nakano O; Abe S; Kamimura H; Sakamaki A; Kamimura K; Tsuchiya A; Takamura M; Yamagiwa S; Terai S
    BMC Cancer; 2018 Jul; 18(1):756. PubMed ID: 30041616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of sarcopenic visceral obesity in hepatocellular carcinoma treated with TACE.
    Li Y; Hou J; Chen R
    Medicine (Baltimore); 2023 Jul; 102(27):e34292. PubMed ID: 37417609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weighting.
    Hiraoka A; Kumada T; Kariyama K; Tada T; Tani J; Fukunishi S; Atsukawa M; Hirooka M; Tsuji K; Ishikawa T; Takaguchi K; Itobayashi E; Tajiri K; Shimada N; Shibata H; Ochi H; Kawata K; Yasuda S; Toyoda H; Ohama H; Nouso K; Tsutsui A; Nagano T; Itokawa N; Hayama K; Arai T; Imai M; Koizumi Y; Nakamura S; Joko K; Michitaka K; Hiasa Y; Kudo M;
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1812-1819. PubMed ID: 33171524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body composition predicts prognosis of hepatocellular carcinoma patients undergoing immune checkpoint inhibitors.
    Xiong B; Fu B; Wu Y; Gao F; Hou C
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11607-11617. PubMed ID: 37400572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. "Sarcopenia and intramuscular fat deposition are associated with poor survival in Indonesian patients with hepatocellular carcinoma: a retrospective study".
    Mardian Y; Yano Y; Ratnasari N; Choridah L; Wasityastuti W; Setyawan NH; Hayashi Y
    BMC Gastroenterol; 2019 Dec; 19(1):229. PubMed ID: 31888500
    [TBL] [Abstract][Full Text] [Related]  

  • 12.  Sarcopenia predicts reduced survival in patients with hepatocellular carcinoma at first diagnosis.
    Begini P; Gigante E; Antonelli G; Carbonetti F; Iannicelli E; Anania G; Imperatrice B; Pellicelli AM; Fave GD; Marignani M
    Ann Hepatol; 2017 Jan-Feb 2017; 16(1):107-114. PubMed ID: 28051799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of muscle measurement using the standardized phase of computed tomography in patients with advanced ovarian cancer.
    Huang CY; Sun FJ; Lee J
    Nutrition; 2020 Apr; 72():110642. PubMed ID: 31986319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma.
    Meza-Junco J; Montano-Loza AJ; Baracos VE; Prado CM; Bain VG; Beaumont C; Esfandiari N; Lieffers JR; Sawyer MB
    J Clin Gastroenterol; 2013; 47(10):861-70. PubMed ID: 23751844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Yttrium-90 radioembolization for hepatocellular carcinoma: Outcome prediction with MRI derived fat-free muscle area.
    Faron A; Sprinkart AM; Pieper CC; Kuetting DLR; Fimmers R; Block W; Meyer C; Thomas D; Attenberger U; Luetkens JA
    Eur J Radiol; 2020 Apr; 125():108889. PubMed ID: 32087468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
    PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Sarcopenia and AFP Level in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma.
    Acosta LF; Galuppo R; García CR; Villacorta E; Dugan A; Castellanos AL; Gedaly R; Lee JT
    J Surg Res; 2019 Jun; 238():10-15. PubMed ID: 30721781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Body Composition Changes in Hepatocellular Carcinoma: Prediction of Survival to Transcatheter Arterial Chemoembolization in Combination With Clinical Prognostic Factors.
    Zheng X; Cao F; Qian L; Dong J
    Cancer Control; 2021; 28():10732748211038445. PubMed ID: 34569304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenia impairs survival in patients with potentially curable hepatocellular carcinoma.
    Levolger S; van Vledder MG; Muslem R; Koek M; Niessen WJ; de Man RA; de Bruin RW; Ijzermans JN
    J Surg Oncol; 2015 Aug; 112(2):208-13. PubMed ID: 26266324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subcutaneous Fat Thickness of the Lower Limb is Associated with Trunk Muscle Mass in Patients with Hepatocellular Carcinoma: A Simple Assessment for Sarcopenia Using Conventional Ultrasonography.
    Sakai M; Kawaguchi T; Koya S; Hirota K; Matsuse H; Torimura T
    Kurume Med J; 2022 Nov; 67(2.3):97-105. PubMed ID: 36130884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.